Skip to content

13G/A filed by BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND L P and 9 other reporting persons reported 8,655,393 ELDN shares, 9.99% of the class, as of 2026-09-30, in a 13G/A accepted by EDGAR 2026-11-16 21:10:34 UTC.

Accession
0000921895-26-003175
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

Stake

Shares
8,655,393
Percent of class
9.99%
Event date
2026-09-30

How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.

Read for the filer group BVF INC/IL.

Reporting persons

PersonTypeSole votingShared votingSole dispositiveShared dispositiveAggregatePercent
BIOTECHNOLOGY VALUE FUND L PPN06,061,39006,061,3906,061,3907%
BVF I GP LLCOO06,061,39006,061,3906,061,3907%
BIOTECHNOLOGY VALUE FUND II LPPN02,173,90502,173,9052,173,9052.6%
BVF II GP LLCOO02,173,90502,173,9052,173,9052.6%
Biotechnology Value Trading Fund OS LPPN0377,0150377,015377,0150.4%
BVF Partners OS Ltd.CO0377,0150377,015377,0150.4%
BVF GP HOLDINGS LLCOO08,235,29508,235,2958,235,2959.5%
BVF PARTNERS L P/ILIA,PN08,655,39308,655,3938,655,3939.99%
BVF INC/ILCO08,655,39308,655,3938,655,3939.99%
LAMPERT MARK NIN08,655,39308,655,3938,655,3939.99%